Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anja Schweizer, Serge Halimi & Sylvie Dejager. (2014) Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan. Vascular Health and Risk Management 10, pages 15-24.
Read now
Read now
Saud Al Sifri. (2012) Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes, Metabolic Syndrome and Obesity 5, pages 293-294.
Read now
Read now
Articles from other publishers (19)
Lina Abdallah Al Rifai, Lama Soubra, Mohamed Hassanein & Mohamed Ezzat Khamis Amin. (2022) Comprehensive care for patients with diabetes in Ramadan: A module for pharmacy students and pharmacists. Saudi Pharmaceutical Journal 30:5, pages 619-628.
Crossref
Crossref
Mahmoud Nassar, Thoraya Mohamed Ahmed, Nilly Helmy AbdAllah, Khaled El Sayed El Hadidy & Rania El-Sayed Sheir. (2021) The impact of structured diabetes education on glycemic control during Ramadan fasting in diabetic patients in Beni Suef, Egypt. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15:5, pages 102249.
Crossref
Crossref
Khaldoon Abdullah, Molham AL-Habori & Ekram Al-Eryani. (2020) Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives. BioMed Research International 2020, pages 1-12.
Crossref
Crossref
Christina Theodore-Oklota, Nicola Bonner, Holly Spencer, Rob Arbuckle, Chao-Yin Chen & Alison Skrinar. (2018) Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points. Value in Health 21:8, pages 973-983.
Crossref
Crossref
Abbas Ali Mansour. (2018) Attitude of Patients with Diabetes Mellitus toward Fasting Ramadan in Basrah, Iraq. Endocrinology&Metabolism International Journal 6:1.
Crossref
Crossref
Mohamed Hassanein, Akram Echtay, Ahmed Hassoun, Monira Alarouj, Bachar Afandi, Raffi Poladian, Abdullah Bennakhi, Maciej Nazar, Paul Bergmans, Sofia Keim, Gill Hamilton & Sami T. Azar. (2017) Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS). International Journal of Clinical Practice 71:10, pages e12991.
Crossref
Crossref
Mubin Mustafa Kiyani, Aamir Raoof Memon, Mian Imran Amjad, Muhammad Rifaqat Ameer, Muhammad Sadiq & Tariq Mahmood. (2015) Study of Human Biochemical Parameters During and After Ramadan. Journal of Religion and Health 56:1, pages 55-62.
Crossref
Crossref
Abdallah M. BeanoMohammad A. ZmailiZaid H. GheithAhmad M. NaserMunther S. MomaniAl-Motassem F. YousefAyman A. Zayed. (2017) Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety. Endocrinology and Metabolism 32:2, pages 265.
Crossref
Crossref
Mohamed Khattab, Khalifa Mahmoud & Inass Shaltout. (2016) Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study. Diabetes Therapy 7:3, pages 551-560.
Crossref
Crossref
Saud Al Sifri & Kashif Rizvi. (2016) Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence. Diabetes Therapy 7:2, pages 221-240.
Crossref
Crossref
L. Monnier, A. El Azrak, N. Lessan, D. Rochd, C. Colette & F. Bonnet. (2015) Ramadan and diabetes: What we see, learn and understand from continuous glucose monitoring. Diabetes & Metabolism 41:6, pages 456-462.
Crossref
Crossref
L. J. Gray, J. Dales, E. M. Brady, K. Khunti, W. Hanif & M. J. Davies. (2015) Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism 17:7, pages 639-648.
Crossref
Crossref
Émilie Héliniak, Hassan Sari, Odile Chambin, Yves Michiels & Francois Pillon. (2015) Diabète et ramadan, une pratique à risque. Actualités Pharmaceutiques 54:547, pages 48-52.
Crossref
Crossref
Kerry Wilbur, Kawthar Al Tawengi & Eman Remoden. (2014) Diabetes patient management by pharmacists during Ramadan. BMC Health Services Research 14:1.
Crossref
Crossref
Mohamed E. K. Amin & Betty Chewning. (2014) Community pharmacists’ knowledge of diabetes management during Ramadan in Egypt. International Journal of Clinical Pharmacy 36:6, pages 1213-1221.
Crossref
Crossref
E. M. Brady, M. J. Davies, L. J. Gray, M. A. Saeed, D. Smith, W. Hanif & K. Khunti. (2014) A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial. Diabetes, Obesity and Metabolism 16:6, pages 527-536.
Crossref
Crossref
M. A. AlMaatouq, M. Al-Arouj, A. Amod, S. H. Assaad-Khalil, S. N. Assaad, S. T. Azar, K. Esmat, A. A. K. Hassoun, N. Jarrah & S. Zatari. (2014) Barriers to the delivery of optimal antidiabetic therapy in the Middle East and Africa. International Journal of Clinical Practice 68:4, pages 503-511.
Crossref
Crossref
Melanie Yee Lee Siaw, Daniel Ek Kwang Chew, Rinkoo Dalan, Shaikh Abdul Kader Kamaldeen Abdul Shakoor, Noorani Othman, Chor Hui Choo, Nur Hidayah Shamsuri, Siti Nurhana Abdul Karim, Sui Yung Chan & Joyce Yu-Chia Lee. (2014) Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study. International Journal of Endocrinology 2014, pages 1-6.
Crossref
Crossref
Serge Halimi, Marc Levy, Dominique Huet, Stéphane Quéré & Sylvie Dejager. (2013) Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study. Diabetes Therapy 4:2, pages 385-398.
Crossref
Crossref